166 related articles for article (PubMed ID: 8692814)
1. Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase.
Robinson WE; Reinecke MG; Abdel-Malek S; Jia Q; Chow SA
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6326-31. PubMed ID: 8692814
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
3. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
[TBL] [Abstract][Full Text] [Related]
4. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase.
McDougall B; King PJ; Wu BW; Hostomsky Z; Reinecke MG; Robinson WE
Antimicrob Agents Chemother; 1998 Jan; 42(1):140-6. PubMed ID: 9449274
[TBL] [Abstract][Full Text] [Related]
5. Dicaffeoyltartaric acid analogues inhibit human immunodeficiency virus type 1 (HIV-1) integrase and HIV-1 replication at nontoxic concentrations.
Reinke RA; King PJ; Victoria JG; McDougall BR; Ma G; Mao Y; Reinecke MG; Robinson WE
J Med Chem; 2002 Aug; 45(17):3669-83. PubMed ID: 12166940
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
7. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.
Pluymers W; Neamati N; Pannecouque C; Fikkert V; Marchand C; Burke TR; Pommier Y; Schols D; De Clercq E; Debyser Z; Witvrouw M
Mol Pharmacol; 2000 Sep; 58(3):641-8. PubMed ID: 10953059
[TBL] [Abstract][Full Text] [Related]
8. Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase.
Mazumder A; Gazit A; Levitzki A; Nicklaus M; Yung J; Kohlhagen G; Pommier Y
Biochemistry; 1995 Nov; 34(46):15111-22. PubMed ID: 7578125
[TBL] [Abstract][Full Text] [Related]
9. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
10. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules.
Farnet CM; Wang B; Lipford JR; Bushman FD
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9742-7. PubMed ID: 8790401
[TBL] [Abstract][Full Text] [Related]
12. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.
Zhu K; Cordeiro ML; Atienza J; Robinson WE; Chow SA
J Virol; 1999 Apr; 73(4):3309-16. PubMed ID: 10074185
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of human immunodeficiency virus integrase.
Fesen MR; Kohn KW; Leteurtre F; Pommier Y
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2399-403. PubMed ID: 8460151
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
15. Chicoric acid analogues as HIV-1 integrase inhibitors.
Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 (HIV-1) integrase: resistance to diketo acid integrase inhibitors impairs HIV-1 replication and integration and confers cross-resistance to L-chicoric acid.
Lee DJ; Robinson WE
J Virol; 2004 Jun; 78(11):5835-47. PubMed ID: 15140981
[TBL] [Abstract][Full Text] [Related]
17. Hydroxylated aromatic inhibitors of HIV-1 integrase.
Burke TR; Fesen MR; Mazumder A; Wang J; Carothers AM; Grunberger D; Driscoll J; Kohn K; Pommier Y
J Med Chem; 1995 Oct; 38(21):4171-8. PubMed ID: 7473544
[TBL] [Abstract][Full Text] [Related]
18. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
19. The first integrase inhibitor.
Smart T
GMHC Treat Issues; 1996 Jan; 10(1):8-9. PubMed ID: 11363377
[TBL] [Abstract][Full Text] [Related]
20. Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase.
King PJ; Robinson WE
J Virol; 1998 Oct; 72(10):8420-4. PubMed ID: 9733896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
